CRBU vs. VB
CRBU (Caribou Biosciences, Inc.) is a stock, while VB (Vanguard Small-Cap ETF) is Small Cap Blend Equities fund tracking the CRSP US Small Cap Index. Over the past 3 years, CRBU returned -26.42%/yr vs 15.96%/yr for VB. At a 0.48 correlation, their price movements are largely independent.
Performance
CRBU vs. VB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRBU achieves a 20.75% return, which is significantly higher than VB's 12.15% return.
CRBU
- 1D
- -7.02%
- 1M
- -1.54%
- YTD
- 20.75%
- 6M
- 1.05%
- 1Y
- 76.15%
- 3Y*
- -26.42%
- 5Y*
- —
- 10Y*
- —
VB
- 1D
- -2.44%
- 1M
- -0.91%
- YTD
- 12.15%
- 6M
- 11.58%
- 1Y
- 26.81%
- 3Y*
- 15.96%
- 5Y*
- 6.73%
- 10Y*
- 10.96%
CRBU vs. VB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CRBU Caribou Biosciences, Inc. | 20.75% | 0.00% | -72.25% | -8.76% | -58.38% | -7.54% |
VB Vanguard Small-Cap ETF | 12.15% | 8.87% | 14.17% | 18.22% | -17.51% | 3.42% |
Correlation
The correlation between CRBU and VB is 0.48, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.48 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.48 |
Correlation (All Time) Calculated using the full available price history since Jul 26, 2021 | 0.48 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRBU vs. VB — Risk / Return Rank
CRBU
VB
CRBU vs. VB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Caribou Biosciences, Inc. (CRBU) and Vanguard Small-Cap ETF (VB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CRBU | VB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.72 | ||
| Sortino ratioReturn per unit of downside risk | -0.59 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.29 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 1.50 | 3.00 | -1.50 |
| Martin ratioReturn relative to average drawdown | 2.64 | 11.02 | -8.38 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CRBU | VB | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.92 | 1.64 | -0.72 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.33 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.51 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.41 | 0.44 | -0.85 |
Drawdowns
CRBU vs. VB - Drawdown Comparison
The maximum CRBU drawdown since its inception was -97.58%, which is greater than VB's maximum drawdown of -59.56%. Use the drawdown chart below to compare losses from any high point for CRBU and VB.
Loading charts...
Drawdown Indicators
| CRBU | VB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.58% | -59.56% | -38.02% |
Max Drawdown (1Y)Largest decline over 1 year | -51.06% | -8.98% | -42.08% |
Max Drawdown (3Y)Largest decline over 3 years | -91.12% | -25.36% | -65.76% |
Max Drawdown (5Y)Largest decline over 5 years | — | -28.15% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -42.05% | — |
Current DrawdownCurrent decline from peak | -93.66% | -2.44% | -91.22% |
Average DrawdownAverage peak-to-trough decline | -79.30% | -8.43% | -70.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.96% | 2.44% | +26.52% |
Volatility
CRBU vs. VB - Volatility Comparison
Caribou Biosciences, Inc. (CRBU) has a higher volatility of 22.95% compared to Vanguard Small-Cap ETF (VB) at 4.84%. This indicates that CRBU's price experiences larger fluctuations and is considered to be riskier than VB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRBU | VB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.95% | 4.84% | +18.11% |
Volatility (6M)Calculated over the trailing 6-month period | 49.58% | 11.98% | +37.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 83.41% | 16.45% | +66.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 86.84% | 20.77% | +66.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.84% | 21.43% | +65.41% |
Dividends
CRBU vs. VB - Dividend Comparison
CRBU has not paid dividends to shareholders, while VB's dividend yield for the trailing twelve months is around 1.21%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRBU Caribou Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VB Vanguard Small-Cap ETF | 1.21% | 1.33% | 1.30% | 1.55% | 1.59% | 1.24% | 1.14% | 1.39% | 1.67% | 1.35% | 1.50% | 1.48% |
Frequently Asked Questions
CRBU and VB have a correlation of 0.48, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRBU has higher volatility (22.95%) compared to VB (4.84%). In terms of maximum drawdown, CRBU dropped -97.58% vs VB's -59.56%.
VB currently has the higher Sharpe Ratio (1.64 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRBU and VB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer